Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401

By Takayama Koichi   Inoue Koji   Tokunaga Shoji   Matsumoto Takemasa   Oshima Tsukasa   Kawasaki Masayuki   Imanaga Tomotoshi   Kuba Mutsuo   Takeshita Masafumi   Harada Taishi   Shioyama Yoshiyuki   Nakanishi Yoichi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1353-1359

Springer Publishing Company

Access to resources Recommend Favorite

Results of a Phase II Study of Weekly Paclitaxel Plus Carboplatin in Advanced Carcinoma of Unknown Primary Origin: A Reasonable Regimen for the Community-Based Clinic?

By Berry William   Elkordy Maha   O'Rourke Mark   Khan Myrna   Asmar Lina  

Cancer Investigation, Vol. 25, Iss. 1, 2007-01 ,pp. : 27-31

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of weekly paclitaxel and carboplatin in previously untreated patients with advanced non-small-cell lung cancer

By Kallab Andre   Nalamolu Yasolatha   Dainer Paul   Jillella Anand  

Medical Oncology, Vol. 22, Iss. 2, 2005-06 ,pp. : 145-151

Humana Press, Inc

Access to resources Recommend Favorite

A pilot study of combination chemotherapy with paclitaxel, pirarubicin, and carboplatin (TPC) for endometrial carcinoma

By Hongo Atsushi   Kusumoto Tomoyuki   Nakamura Keiichiro   Seki Noriko   Kodama Junichi   Hiramatsu Yuji  

International Journal of Clinical Oncology, Vol. 15, Iss. 5, 2010-10 ,pp. : 476-483

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma - a multicentre phase I study

By Giannakakis T.   Ziras N.   Kakolyris S.   Mavroudis D.   Androulakis N.   Agelaki S.   Parashos M.   Sarra E.   Dimou T.   Hatzidaki D.   Vlachonikolis J.   Georgoulias V.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 742-747

Elsevier

Access to resources Recommend Favorite